These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 14059809)

  • 1. [ADMINISTRATION OF ALDACTONE (SPIRONOLACTONE) IN THE TREATMENT OF DROPSY AND ASCITES].
    BALABANSKI LT
    Suvr Med (Sofiia); 1963; 14():19-25. PubMed ID: 14059809
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the use of Aldactone and Aldactone A in the treatment of hepatic ascites.
    SHALDON S; RYDER JA; GARSENSTEIN M
    Gut; 1963 Mar; 4(1):16-9. PubMed ID: 13988398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ascites in hepatic cirrhosis with the combined use of aldactone and chlorothiazide.
    HSIEN L; MIN-KUEI T; CHIA-SHUN C; CH'UNG-CHU L; CHUN Y; SHIH-YAO L; FU-YUAN F; SUNG-TS'E L
    Chin Med J; 1962 Aug; 81():543-7. PubMed ID: 13955289
    [No Abstract]   [Full Text] [Related]  

  • 4. [PERSONAL EXPERIENCE ON THE ROLE OF SPIRONOLACTONE IN THE TREATMENT OF EDEMA].
    GEORGOPOULOS AJ; LAPPAS D; TOUNTAS C
    Rev Med Moyen Orient; 1963; 20():513-20. PubMed ID: 14118405
    [No Abstract]   [Full Text] [Related]  

  • 5. [PERSONAL EXPERIENCE ON THE ROLE OF SPIRONOLACTONE IN THE TREATMENT OF EDEMA].
    GEORGOPOULOS AJ; LAPPAS D; TOUNTAS C
    Rev Med Moyen Orient; 1963; 20():513-20. PubMed ID: 14114223
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldactone: a physiologically new approach to the age-old problem of ascites.
    VEITH I
    Res Serv Med; 1960; 52():3-28. PubMed ID: 13780606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of the micronized aldactone - altizide combination in the treatment of edema].
    Lekiefre J; Foucault M; Basin B; Delemotte M
    Lille Med; 1966; 11(6):730-3. PubMed ID: 5942193
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the peculiarities of action of aldactone in edema].
    Eliseev OM
    Klin Med (Mosk); 1968 Jul; 46(7):60-5. PubMed ID: 5715090
    [No Abstract]   [Full Text] [Related]  

  • 9. [POST-INFECTIOUS EDEMA TREATED BY ALDACTONE IN AN 8 MONTH-OLD CHILD].
    BOUISSEAU J
    Arch Fr Pediatr; 1964 Dec; 21():1230-1. PubMed ID: 14248333
    [No Abstract]   [Full Text] [Related]  

  • 10. SPIRONOLACTONE IN ASCITES OF HEPATIC CIRRHOSIS: PRELIMINARY OBSERVATIONS.
    CARPENTER CJ; MITRA P
    Bull Calcutta Sch Trop Med; 1963 Jul; 11():114-5. PubMed ID: 14068663
    [No Abstract]   [Full Text] [Related]  

  • 11. SPIRONOLACTONE IN REFRACTORY ASCITES IN HEPATIC CIRRHOSIS.
    SHAH MJ; KHOKHANI RC; VAIDYA AB; SHETH UK
    J Assoc Physicians India; 1963 Oct; 11():837-42. PubMed ID: 14071784
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical applications of spironolactone].
    SALA G; D'AMICO G
    Minerva Med; 1963 Mar; 54():838-9. PubMed ID: 13990998
    [No Abstract]   [Full Text] [Related]  

  • 13. THE STUDY OF THE EFFECT OF SPIROLACTONES ON ASCITES AND INTRASPLENIC PRESSURE IN BILHARZIAL LIVER CIRRHOSIS.
    ELMAHALLAWI MN; SAYED WA; EZZAT E
    J Egypt Med Assoc; 1963; 46():553-63. PubMed ID: 14066551
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the use of spironolactone-polysorbate 80].
    GRAZIANI G; MOLE R
    Minerva Med; 1963 Mar; 54():837-8. PubMed ID: 13950013
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients.
    Matsumoto Y; Kageyama S; Yakushigawa T; Arihara K; Sugiyama T; Mori Y; Sugiyama H; Ohmura H; Shio N
    Cardiology; 2009; 114(1):32-8. PubMed ID: 19342857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of edema.
    O'Brien JG; Chennubhotla SA; Chennubhotla RV
    Am Fam Physician; 2005 Jun; 71(11):2111-7. PubMed ID: 15952439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dropsy, Dante, Master Adam and a contradiction in semeiotics].
    PAZZINI A
    Athena; 1953 May; 19(5):227-30. PubMed ID: 13093523
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
    Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.